Virtual Engineering Week 2020 is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Virtual Engineering Week Schedule Viewer


Virtual Engineering Week is bringing a full week of best-in-class education to the global design, engineering, and manufacturing communities. Join us each morning to hear from medical device industry professionals during the Medtech Mornings series, and in the afternoons to learn from engineering and manufacturing experts in areas like 3D printing, smart manufacturing, packaging, materials and sustainability, and career development.

All times listed below are PST (Pacific Standard Time).

Overcoming the Limitations of Additive Manufacturing

Dayton Horvath  (Industry Analyst & Consultant/Principal - NewCap Partners, NewCap Partners)

Date: Monday, November 30

Time: 9:30am - 10:00am

Track: MedTech Mornings: Medical 3D Printing & Additive Manufacturing

Vault Recording: TBD

There are 7 distinct additive manufacturing processes as defined by ASTM. In recent years, technical innovations have expanded beyond these original seven processes as well as blurred the lines between them. With hundreds of companies offering 3D printers, printable materials, related equipment, and specialized software, navigating the industry and its performance claims is a task in itself. This talk will provide an analytical approach to interpreting specifications for the more common technology categories and commentary around unspoken weaknesses and limitations in relation to medical 3D printing. For example, what implantable medical device characteristics are achievable with any of today’s 3D printing technology categories? Additionally, the current challenges facing the broader industrial 3D printing workflow are discussed with commentary on how they may be overcome looking forward. Specific cases in materials biocompatibility, post-processing, quality control, and economic viability demonstrate why directly printing medical devices has yet to displace other manufacturing methods as the industry standard.